Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Science 37
CRO
Science 37 agrees to be acquired by eMed in deal valued at $38M
Science 37 has agreed to be acquired by telehealth and diagnostics provider eMed in an all-cash tender offer valued at approximately $38 million.
Joseph Keenan
Jan 29, 2024 9:30am
Science 37 tapped for Synlogic's phase 3 trial of PKU treatment
Jul 12, 2023 3:25pm
Veeva inks deal with 40 CROs for digital clinical trial platform
Oct 20, 2022 4:00am
Decentralized trials an agile solution for cancer R&D
Jun 17, 2022 3:30pm
Canceled COVID studies hit Science 37's earnings
May 11, 2022 7:50am
Worldwide Clinical teams with Science 37 for more remote trials
Jan 19, 2022 9:45am
